Jump to section
They have a mission to accelerate operations, advance quality and regulatory assurance, improve data management and increase patient engagement.
Traditional clinical trial systems are largely obsolete and slow teams down. R.grid is setting out to manage clinical trials with a flexible platform which significantly reduces administrative work.
R.grid is founded on the core principles of being fast and intuitive to use, being patient-centric, improving research with open recruitment and AI, and being compliant with major regulators in the UK, EU, and USA, including DPA 2018, GDPR, and HIPAA.
Through their services, R.grid helps provide 23.3 million insights from clinical research, amounting to a 30% decrease in costs and a 90% increase in administrative efficiency.
Kirsty
Company Specialist at Welcome to the Jungle
Nov 2024
$6.5m
SEED
Mar 2020
$1.7m
SEED
This company has top investors
Amber Michelle Hill
(CEO)Background in translational and biomedical neuroscience, studied at UCL and Harvard Extension School. After working for the NHS as a researcher at UCL and a Fellow at the Royal Academy of Engineering, she founded R.grid in July 2019.